| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72888-054-01 | 72888-054 | HUMAN PRESCRIPTION DRUG | METOLAZONE | METOLAZONE | TABLET | ORAL | 20210820 | N/A | ANDA | ANDA215184 | Advagen Pharma Limited | METOLAZONE | 10 mg/1 | 100 TABLET in 1 BOTTLE (72888-054-01) |
| 72888-052-01 | 72888-052 | HUMAN PRESCRIPTION DRUG | METOLAZONE | METOLAZONE | TABLET | ORAL | 20210820 | N/A | ANDA | ANDA215184 | Advagen Pharma Limited | METOLAZONE | 2.5 mg/1 | 100 TABLET in 1 BOTTLE (72888-052-01) |
| 72888-053-01 | 72888-053 | HUMAN PRESCRIPTION DRUG | METOLAZONE | METOLAZONE | TABLET | ORAL | 20210820 | N/A | ANDA | ANDA215184 | Advagen Pharma Limited | METOLAZONE | 5 mg/1 | 100 TABLET in 1 BOTTLE (72888-053-01) |
| 50090-6972-0 | 50090-6972 | HUMAN PRESCRIPTION DRUG | METOLAZONE | METOLAZONE | TABLET | ORAL | 20231221 | N/A | ANDA | ANDA215184 | A-S Medication Solutions | METOLAZONE | 2.5 mg/1 | 30 TABLET in 1 BOTTLE (50090-6972-0) |